• 🕗Cholesterol Report from the American College of Cardiology Ep. 286

  • Apr 11 2025
  • Duración: 9 m
  • Podcast

🕗Cholesterol Report from the American College of Cardiology Ep. 286

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Send us a text

    Dr. Michael Koren shares insights from his presentation at the American College of Cardiology meeting in Chicago about a groundbreaking oral PCSK9 inhibitor that could lower cholesterol by 80% when combined with a statin. The development represents a significant advancement in treatment options for the 20% of patients who don't respond adequately to statins alone or experience statin intolerance. They also chat about Chicago and the importance of things in moderation.

    Be a part of advancing science by participating in clinical research.

    Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.com

    Listen on Spotify
    Listen on Apple Podcasts
    Watch on YouTube

    Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

    Follow us on Social Media:
    Facebook
    Instagram
    X (Formerly Twitter)
    LinkedIn

    Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

    Music: Storyblocks - Corporate Inspired

    Thank you for listening!
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre 🕗Cholesterol Report from the American College of Cardiology Ep. 286

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles